Adjuvant aromatase inhibitor therapy for breast cancer

PsycEXTRA Dataset ◽

10.1037/e459052008-007 ◽

2008 ◽

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Inhibitor Therapy ◽

Aromatase Inhibitor Therapy

Download Full-text

Neuropsychological Functioning in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitor Therapy

PsycEXTRA Dataset ◽

10.1037/e684272011-001 ◽

2011 ◽

Author(s):

Jacqueline R. Weaver ◽

Shauna M. Stark ◽

Karineh T. Shaverdi ◽

Stacie Jeter ◽

Jane Zorzi ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Neuropsychological Functioning ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy

Download Full-text

Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study

Case Medical Research ◽

10.31525/ct1-nct04256941 ◽

2020 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Metastatic Breast ◽

Inhibitor Therapy ◽

Aromatase Inhibitor Therapy ◽

Activating Mutation

Download Full-text

Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trial

Contemporary Clinical Trials ◽

10.1016/j.cct.2011.04.012 ◽

2011 ◽

Vol 32 (5) ◽

pp. 704-709 ◽

Author(s):

Sharon Kilbreath ◽

Kathryn M. Refshauge ◽

Jane Beith ◽

Leigh Ward ◽

Kate Sawkins ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Controlled Trial ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Controlled Trial ◽

Inhibitor Therapy ◽

Aromatase Inhibitor Therapy ◽

Randomized Controlled ◽

Prevention Of Osteoporosis

Download Full-text

Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy

Menopause The Journal of The North American Menopause Society ◽

10.1097/gme.0b013e3181a5d0d6 ◽

2009 ◽

Vol 16 (4) ◽

pp. 653-659 ◽

Author(s):

Julie L. Otte ◽

David Flockhart ◽

Daniel Hayes ◽

Anna Maria Storniolo ◽

Vered Stearns ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Survivors ◽

Aromatase Inhibitor ◽

Breast Cancer Survivors ◽

Inhibitor Therapy ◽

Hot Flash ◽

Aromatase Inhibitor Therapy ◽

Download Full-text

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer

New England Journal of Medicine ◽

10.1056/nejmoa2104162 ◽

2021 ◽

Vol 385 (5) ◽

pp. 395-405 ◽

Author(s):

Michael Gnant ◽

Florian Fitzal ◽

Gabriel Rinnerthaler ◽

Guenther G. Steger ◽

Sigrun Greil-Ressler ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Breast Cancer ◽

Inhibitor Therapy ◽

Aromatase Inhibitor Therapy

Download Full-text

A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy

Current Oncology ◽

10.3747/co.v18i6.909 ◽

2011 ◽

Vol 18 (6) ◽

Author(s):

A. Robidoux ◽

E. Rich ◽

N.J. Bureau ◽

S. Mader ◽

D. Laperrière ◽

...

Keyword(s):

Breast Cancer ◽

Pilot Study ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Musculoskeletal Pain ◽

Postmenopausal Breast Cancer ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy ◽

Prospective Pilot Study

Download Full-text

Are Estring® and Vagifem® Equally Effective and Safe for the Treatment of Urogenital Atrophy in Breast Cancer Patients on Aromatase Inhibitor Therapy?

Clinical Oncology ◽

10.1016/j.clon.2012.06.009 ◽

2012 ◽

Vol 24 (8) ◽

pp. e128-e129 ◽

Author(s):

C.E. Simmons ◽

I. Kuchuk ◽

O.C. Freedman ◽

T. Colgan ◽

A. Dodd ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy ◽

Urogenital Atrophy

Download Full-text

Study of Neurobehavioral Symptoms and Impairments in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitor Therapy.

10.1158/0008-5472.sabcs-09-4084 ◽

2009 ◽

Author(s):

J. Weaver ◽

S. Stark ◽

S. Stark ◽

K. Shahverdi ◽

S. Jeter ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Cancer Patients ◽

Inhibitor Therapy ◽

Breast Cancer Patients ◽

Aromatase Inhibitor Therapy ◽

Neurobehavioral Symptoms

Download Full-text

Abstract P6-04-21: AIB1 expression specifically predicts breast cancer patient response to aromatase inhibitor therapy

10.1158/0008-5472.sabcs12-p6-04-21 ◽

2012 ◽

Author(s):

D Vareslija ◽

J O'Hara ◽

P Tibbitts ◽

J McBryan ◽

Y Hao ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patient ◽

Breast Cancer Patient ◽

Aromatase Inhibitor ◽

Inhibitor Therapy ◽

Patient Response ◽

Aromatase Inhibitor Therapy

Download Full-text

Abstract P1-13-07: A phase III study of fulvestrant 500 mg versus 250 mg in postmenopausal Chinese women with advanced breast cancer and disease progression following failure on prior antiestrogen or aromatase inhibitor therapy: Supporting superior clinical benefit for the

10.1158/1538-7445.sabcs14-p1-13-07 ◽

2015 ◽

Author(s):

Zefei Jiang ◽

Qingyuan Zhang ◽

Zhimin Shao ◽

Kunwei Shen ◽

Li Li ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Aromatase Inhibitor ◽

Disease Progression ◽

Clinical Benefit ◽

Chinese Women ◽

Inhibitor Therapy ◽

Phase Iii ◽

Aromatase Inhibitor Therapy ◽

Phase Iii Study

Download Full-text